Correlates of toxicity in metastatic melanoma patients treated with ipilimumab.

被引：0
|
作者：
Valpione, Sara
Pigozzo, Jacopo
Pasquali, Sandro
Piccin, Luisa
Mocellin, Simone
Campana, Luca Giovanni
Chiarion-Sileni, Vanna
机构：
[1] Univ Padua, Padua, Italy
[2] Ist Oncol Veneto IRCCS, Padua, Italy
[3] Univ Naples Federico II, Padua, Italy
[4] Univ Padua, Dept Oncol & Surg Sci, Padua, Italy
[5] Veneto Oncol Inst, Padua, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e21010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21010
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab
    Koguchi, Yoshinobu
    Hoen, Helena M.
    Bambina, Shelly A.
    Rynning, Michael D.
    Fuerstenberg, Richard K.
    Curti, Brendan D.
    Urba, Walter J.
    Milburn, Christina
    Bahjat, Frances Rena
    Korman, Alan J.
    Bahjat, Keith S.
    CANCER RESEARCH, 2015, 75 (23) : 5084 - 5092
  • [42] Treatment of in-transit and metastatic melanoma in two patients treated with ipilimumab and topical imiquimod
    Joseph, Richard W.
    Cappel, Mark
    Tzou, Katherine
    Bagaria, Sanjay
    Gilstrap, Cheryl
    Swaika, Abhisek
    Jambusaria-Pahlajani, Anokhi
    MELANOMA RESEARCH, 2016, 26 (04) : 409 - 412
  • [43] Real-world survival results of metastatic melanoma patients treated with ipilimumab in the Netherlands
    Jochems, A.
    Schouwenburg, M.
    Aarts, M.
    van den Berkmortel, F.
    van den Eertwegh, A.
    Groenewegen, G.
    de Groot, J-W.
    Haanen, J. B. A. G.
    Hospers, G.
    Kapiteijn, E.
    Koornstra, R.
    Kruit, W.
    Leeneman, B.
    Louwman, M.
    Piersma, D.
    van Rijn, R.
    Ten Tije, A. J.
    Vreugdenhil, G.
    Wouters, M.
    van der Hoeven, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [44] Development of brain metastases in patients with metastatic melanoma treated with ipilimumab plus temozolomide.
    Wang, Jennifer
    Patel, Sapna Pradyuman
    Hwu, Wen-Jen
    Kim, Kevin B.
    Papadopoulos, Nicholas E.
    Hwu, Patrick
    Radvanyi, Laszlo George
    Mahoney, Sandy
    Deburr, Tawania L.
    Bassett, Roland
    Bedikian, Agop Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] Use of complementary medicine in metastatic melanoma patients treated with ipilimumab within a clinical trial
    Huebner, Jutta
    Mohr, Peter
    Simon, Jan-Christoph
    Fluck, Michael
    Berking, Carola
    Zimmer, Lisa
    Loquai, Carmen
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 (05): : 508 - 513
  • [46] Letter: cytomegalovirus colitis in a patient treated with ipilimumab for metastatic melanoma
    Bossa, F.
    Perri, F.
    Niro, G.
    Parente, P.
    Graziano, P.
    Andriulli, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (01) : 174 - 175
  • [47] Diarrhoea in a patient with metastatic melanoma:Ipilimumab ileocolitis treated with infliximab
    Rob ME Slangen
    Alfonsus JM van den Eertwegh
    Adriaan A van Bodegraven
    Nanne KH de Boer
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2013, (03) : 80 - 82
  • [48] Comparing radiation therapy and ipilimumab to ipilimumab alone in metastatic melanoma patients
    Patel, Kirtesh R.
    Oliver, Daniel E.
    Okwan-Dadu, Derick
    Liu, Yuan
    Kudchadkar, Ragini R.
    Lawson, David H.
    Khan, Mohammad K.
    CANCER RESEARCH, 2015, 75
  • [49] Toxicity and response to ipilimumab and nivolumab in elderly patients with metastatic melanoma: A multicenter retrospective analysis.
    Pathmanathan, Shivanshan
    Babu, Hari S.
    Dzienis, Marcin Radoslaw
    Azer, Mary
    Eastgate, Melissa A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] Ipilimumab In Previously Treated Patients with Advanced Melanoma
    Sanford, Mark
    BIODRUGS, 2012, 26 (03) : 185 - 193
12345